Trastuzumab Active Not Recruiting Phase 1 Trials for Stage IV Breast Cancer / Stage IV Breast Cancer AJCC v6 and v7 / Invasive Breast Carcinoma / HER2/Neu Positive / Recurrent Breast Carcinoma Treatment

IndicationsStatusPurposePhase
Active Not RecruitingTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT01434303Entinostat, Lapatinib Ditosylate and Trastuzumab in Treating Patients With Locally Recurrent or Distant Relapsed Metastatic Breast Cancer Previously Treated With Trastuzumab Only